Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome

被引:99
作者
Edwards, CJ [1 ]
Lian, TY
Badsha, H
Teh, CL
Arden, N
Chng, HH
机构
[1] Southampton Gen Hosp, Dept Rheumatol, Southampton, Hants, England
[2] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore
关键词
hospitalization; outcome; systemic lupus erythematosus;
D O I
10.1191/0961203303lu452oa
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a retrospective study of patients with systemic lupus erythematosus (SLE) admitted to hospital during a one-year period to describe characteristics associated with a poor outcome. There were 348 episodes of hospitalization of 223 individuals. The cause of admission was clinical flare of SLE (58%), infection (37%) and thromboembolic disease (8%). Readmission occurred in 35.8% and was associated with: active nephritis (HR 2.53, P < 0.01), flare of lupus (HR 2.0, P < 0.01) and more ACR criteria ( HR 1.34 per extra criteria, P < 0.01). Individuals with multiple reasons for admission had a longer duration of stay [one = four days ( 2,6), two = five days (3,7) and three = 9.5 days (6.5,14.5), P < 0.01]. There were 11 deaths (3.2% of admissions). The deaths were due to infection in nine cases ( four with concurrent active SLE). In multivariate modelling, the main predictors of death were: previous multiple admissions (OR 12.4, P < 0.01), the presence of infection (OR 7.3, P < 0.01) and younger age (OR 0.93 per increase of one year, P = 03). The presence of active lupus nephritis and multisystem disease makes readmission more likely and individuals with multiple problems at the time of admission have longer hospital stays. Young patients with frequent readmissions and coexistent infections are most likely to die.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 20 条
[1]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[2]   Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications [J].
Badsha, H ;
Kong, KO ;
Lian, TY ;
Chan, SP ;
Edwards, CJ ;
Chng, HH .
LUPUS, 2002, 11 (08) :508-513
[3]   Morbidity and mortality in systemic lupus erythematosus during a 5-year period -: A multicenter prospective study of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Aydintug, AO ;
Jedryka-Góral, A ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Haga, HJ ;
Mathieu, A ;
Houssiau, F ;
Ruiz-Irastorza, G ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 1999, 78 (03) :167-175
[4]  
D Agate David J, 2003, J Invasive Cardiol, V15, P157
[5]  
DUFFY KNW, 1991, J RHEUMATOL, V18, P1180
[6]   Lupus in Singapore [J].
Edwards, CJ .
LUPUS, 2001, 10 (12) :889-891
[7]  
Hernández-Cruz B, 2001, CLIN EXP RHEUMATOL, V19, P395
[8]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[9]   Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome [J].
Janssen, NM ;
Karnad, DR ;
Guntupalli, KK .
CRITICAL CARE CLINICS, 2002, 18 (04) :729-+
[10]  
Janwityanuchit Sachela, 1993, Journal of the Medical Association of Thailand, V76, P542